Rpo »

Outset Med shares owned by Rpo

Quarter-by-quarter ownership of Outset Med (OM) shares owned by Rpo from 13F filings

Historical chart of Rpo investment in Outset Med

Tip: Access up to 7 years of quarterly data

All positions including Outset Med held by Rpo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outset Med by Rpo

Quarter filed Position value Share count Share price at filing
2023-12-31 $76k 14k 5.41

More positions owned by Rpo

stock
Abrdn Healthcare Investors Sh Ben Int (HQH)
Nuveen Multi-Strategy Income & Growth (JPC)
Abrdn Life Sciences Investor Sh Ben Int (HQL)
Flaherty & Crumrine/Claymore Preferred S (FFC)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Flaherty & Crumrine Dynamic SHS (DFP)
Gabelli Dividend & Income Trust (GDV)
Blackrock Muniyield Fund (MYD)
Calamos Global Dynamic Income Fund (CHW)
Duff & Phelps Global (DPG)
Royce Value Trust (RVT)
Blackrock Munivest Fund II (MVT)
Boulder Growth & Income Fund (STEW)
Capri Holdings SHS (CPRI)

View all positions for Rpo

Top funds holding Outset Med

Jpmorgan Chase & Co
Vanguard Group
Braidwell
Bellevue Group
Mubadala Investment Co PJSC
CAM Group Holding A/S
Partner Fund Management
Assenagon Asset Management
D. E. Shaw & Co
Millennium Management
Bank of New York Mellon
Massachusetts Financial Services
GSA Capital Partners
Norges Bank Investment Management
Citadel Advisors

View all funds holding Outset Med